Log In
Print this Print this

Gelnique, oxybutynin topical gel

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionTopical gel formulation of oxybutynin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today